U.S. Department of Labor Proposes New Disclosure Rules for Pharmacy Benefit Managers
The U.S. Department of Labor is set to introduce a new regulation requiring pharmacy benefit managers (PBMs) to increase transparency regarding their financial dealings. Under the proposed rule, PBMs will be mandated to disclose the specific prices they pay for pharmaceutical products as well as the various payments and rebates they receive from drug manufacturers. This regulatory move aims to shed light on the opaque pricing structures within the pharmaceutical supply chain. By forcing disclosure of these transactions, the Department of Labor intends to provide greater clarity on how PBMs influence drug costs and profit margins, potentially impacting the business models of major healthcare service providers.
Topics: Department of Labor Drug Pricing Transparency Pharmacy Benefit Managers
Read the full article at Seeking Alpha
Part of the story U.S. Department of Labor Issues Final Rule Requiring PBM Fee Transparency (2 articles)